New therapy to tackle treatment-resistant cancers Scientists have developed a therapy that could outsmart cancer cells that have become immune to certain treatments, according to a study published in Cancer Cell.…
David Reddy: delivery of new anti-malaria drugs to developing countries is vital in fight against the disease David Reddy, Medicines for Malaria Venture’s chief executive officer, discusses developments in the fight against the disease ahead of World Malaria Day on 25 April.…
Broadly neutralising antibody shows some success in treating patients with HIV A potent type of antibody therapy trialled in HIV patients for the first time has been shown to reduce the amount of virus in patients’ blood.…
Low doses of sequential antibiotics could treat infections, study finds Sequential therapy with two synergistic antibiotics over a period of 96 hours cleared bacterial infection in an in vitro treatment model of Escherichia coli.…
Combination anti-TB regimen shows bactericidal action, trial indicates A shorter drug regimen for the treatment of tuberculosis is on the horizon, involving moxifloxacin, pretomanid and pyrazinamide.…
Medicines regulators set out priorities for next five yearsMedicines regulators across Europe have set out their priorities for the next five years in a proposed strategy now out for consultation.…
Innovation fund to support antibiotic development on the cardsA global innovation fund worth up to US$2bn could be set up to encourage pharmaceutical companies to search for and develop new classes of antibiotics.…
How the pharmaceutical industry is contributing to antimicrobial resistance Through poor practices, the pharmaceutical industry is adding to the problem of antimicrobial resistance instead of helping to solve it.…
US FDA approves antibiotic combination with new beta-lactamase inhibitor The US Food and Drug Administration has approved a new intravenous antibacterial product, Avycaz, which contains ceftazidime and a new beta-lactamase inhibitor, avibactam.…
US$2bn global innovation fund proposed to tackle antimicrobial resistance A worldwide innovation fund worth up to US$2bn could be set up to encourage the pharmaceutical industry to search for and develop new classes of antibiotics.…